. doi: 10.1016/j.virs.2025.05.012
Citation: Shuting Zhou, Junrui Zhu, Houde Zhao, Zixin Huang, Kangqi Zheng, Fan Xia, Yufan Xu, Guocheng Zhao, Jijie Jiang, En Zhang, Haoyang Nian, Li Cui, Tao Sun, Xiangfeng Wang, Yanjun Zhou, Zhibiao Yang, Zhe Wang. Clofazimine targeting the spike protein and RdRp exhibits highly efficient antiviral activity against porcine epidemic diarrhea virus in vitro .VIROLOGICA SINICA, 2025, 40(3) : 477-490.  http://dx.doi.org/10.1016/j.virs.2025.05.012

氯法齐明通过靶向刺突蛋白和RdRp在体外对猪流行性腹泻病毒表现出高效的抗病毒活性

  • 猪流行性腹泻病毒(PEDV)感染会导致新生仔猪急性水样腹泻,给养猪业造成重大经济损失。本研究表明,氯法齐明(CFZ)在体外以剂量依赖性方式显著抑制PEDV复制,且细胞毒性可忽略不计。通过时间添加实验,我们发现CFZ能有效破坏病毒感染周期的多个阶段。利用CoV-RdRp-Gluc报告系统,我们评估了CFZ对PEDV RNA依赖性RNA聚合酶(RdRp)的抑制作用,并测得其IC50值为0.1364 μM,表明其高效性。分子对接研究进一步证实,CFZ在PEDV的刺突蛋白和RdRp蛋白活性位点具有高结合亲和力。对VeroE6细胞在有无CFZ处理下的转录组分析显示,感染后8小时(hpi)转录活性发生显著变化。此外,CFZ与核苷类似物联用可增强其在体外的抗PEDV效果。本研究强调了CFZ作为抗PEDV潜在治疗药物的可行性。

Clofazimine targeting the spike protein and RdRp exhibits highly efficient antiviral activity against porcine epidemic diarrhea virus in vitro

  • Porcine epidemic diarrhea virus (PEDV) infection causes acute watery diarrhea in neonatal piglets, leading to substantial economic losses within the pig farming industry. This study demonstrates that clofazimine (CFZ) significantly inhibits PEDV replication in a dose-dependent manner in vitro, with negligible cytotoxicity. Findings from our time-of-addition assays indicate that CFZ effectively disrupts multiple stages of the viral infection cycle. Using a CoV-RdRp-Gluc reporter system, we evaluated the potency of CFZ against PEDV RNA-dependent RNA polymerase (RdRp), and determined a low IC50 value of 0.1364 μM. Molecular docking studies further confirmed that CFZ has high binding affinity at the active sites of the spike protein and RdRp protein in PEDV. Transcriptome analysis of Vero E6 cells, with and without CFZ treatment, revealed a significant change in transcriptional activity at 8 h post-infection (hpi). Moreover, the simultaneous application of CFZ and nucleoside analogs showed enhanced the anti-PEDV effect of CFZ in vitro. Our study underscores the potential of CFZ as a viable therapeutic agent against PEDV.

  • 加载中
    1. BALD, D., VILLELLAS, C., LU, P. & KOUL, A. 2017. Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery. mBio, 8, e00272-17.

    2. CHEN, B., DONG, S., YU, L., SI, F., LI, C., XIE, C., YU, R. & LI, Z. 2023. Three Amino Acid Substitutions in the Spike Protein Enable the Coronavirus Porcine Epidemic Diarrhea Virus To Infect Vero Cells. Microbiol Spectr, 11, e0387222.

    3. CHEN, P., WANG, K., HOU, Y., LI, H., LI, X., YU, L., JIANG, Y., GAO, F., TONG, W., YU, H., YANG, Z., TONG, G. & ZHOU, Y. 2019. Genetic evolution analysis and pathogenicity assessment of porcine epidemic diarrhea virus strains circulating in part of China during 2011-2017. Infect Genet Evol, 69, 153-165.

    4. CHOLO, M. C., STEEL, H. C., FOURIE, P. B., GERMISHUIZEN, W. A. & ANDERSON, R. 2012. Clofazimine: current status and future prospects. J Antimicrob Chemother, 67, 290-298.

    5. CHUTIWITOONCHAI, N., AKKARAWONGSAPAT, R., CHANTAWARIN, S., JIARPINITNUN, C., LIWNAREE, B., TEERAVECHYAN, S. & SOODVILAI, S. 2025. Antiviral effect of pinostrobin, a bioactive constituent of Boesenbergia rotunda, against porcine epidemic diarrhea virus. Antiviral Res, 234, 106073.

    6. FERNANDES, R. S., DE GODOY, A. S., SANTOS, I. A., NOSKE, G. D., DE OLIVEIRA, K. I. Z., GAWRILJUK, V. O., GOMES JARDIM, A. C. & OLIVA, G. 2021. Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening. Virus Res, 299, 198388.

    7. GUO, S., ZHANG, Y., LIU, Z., WANG, D., LIU, H., LI, L., CHEN, Q., YANG, D., LIU, Q., GUO, H., MOU, S., CHEN, H. & WANG, X. 2023. Brincidofovir is a robust replication inhibitor against African swine fever virus in vivo and in vitro. Emerg Microbes Infect, 12, 2220572.

    8. HE, W. T., BOLLEN, N., XU, Y., ZHAO, J., DELLICOUR, S., YAN, Z., GONG, W., ZHANG, C., ZHANG, L., LU, M., LAI, A., SUCHARD, M. A., JI, X., TU, C., LEMEY, P., BAELE, G. & SU, S. 2022. Phylogeography Reveals Association between Swine Trade and the Spread of Porcine Epidemic Diarrhea Virus in China and across the World. Mol Biol Evol, 39, msab364.

    9. HUANG, Y., YANG, C., XU, X. F., XU, W. & LIU, S. W. 2020. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin, 41, 1141-1149.

    10. HUANG, Z. X., ZHOU, S. T., WANG, J., YANG, Z. B. & WANG, Z. 2023a. Remdesivir inhibits Porcine epidemic diarrhea virus infection in vitro. Heliyon, 9, e21468.

    11. HUANG, Z. X., ZHOU, S. T., YANG, Z. B. & WANG, Z. 2023b. Molnupiravir Inhibits Porcine Epidemic Diarrhea Virus Infection In Vitro. Viruses, 15, 1317.

    12. JIANG, L., GU, M., XIAO, J., ZHAO, Y., SHEN, F., GUO, X., LI, H., GUO, D., LI, C., ZHU, Q., YANG, D., XING, X. & SUN, D. 2025. Ethyl caffeate as a novel targeted inhibitor of 3CLpro with antiviral activity against porcine epidemic diarrhea virus. Virology, 604, 110406.

    13. KABINGER, F., STILLER, C., SCHMITZOVa, J., DIENEMANN, C., KOKIC, G., HILLEN, H. S., HoBARTNER, C. & CRAMER, P. 2021. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol, 28, 740-746.

    14. KOKIC, G., HILLEN, H. S., TEGUNOV, D., DIENEMANN, C., SEITZ, F., SCHMITZOVA, J., FARNUNG, L., SIEWERT, A., HoBARTNER, C. & CRAMER, P. 2021. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat Commun, 12, 279.

    15. LEANZA, L., O'REILLY, P., DOYLE, A., VENTURINI, E., ZORATTI, M., SZEGEZDI, E. & SZABO, I. 2014. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines. Curr Pharm Des, 20, 189-200.

    16. LI, C., HUANG, J., YU, Y., WAN, Z., CHIU, M. C., LIU, X., ZHANG, S., CAI, J. P., CHU, H., LI, G., CHAN, J. F., TO, K. K., YANG, Z., JIANG, S., YUEN, K. Y., CLEVERS, H. & ZHOU, J. 2023a. Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants. Proc Natl Acad Sci U S A, 120, e2300376120.

    17. LI, C., LI, W., LUCIO DE ESESARTE, E., GUO, H., VAN DEN ELZEN, P., AARTS, E., VAN DEN BORN, E., ROTTIER, P. J. M. & BOSCH, B. J. 2017. Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies. J Virol, 91, e00273-17.

    18. LI, C., SONG, W., CHAN, J. F., CHEN, Y., LIU, F., YE, Z., LAM, A. H., CAI, J., LEE, A. C., WONG, B. H., CHU, H., LUNG, D. C., SRIDHAR, S., CHEN, H., ZHANG, A. J. & YUEN, K. Y. 2023b. Intranasal infection by SARS-CoV-2 Omicron variants can induce inflammatory brain damage in newly weaned hamsters. Emerg Microbes Infect, 12, 2207678.

    19. LI, M., PAN, Y., XI, Y., WANG, M. & ZENG, Q. 2023c. Insights and progress on epidemic characteristics, genotyping, and preventive measures of PEDV in China: A review. Microb Pathog, 181, 106185.

    20. LI, S., ZHU, Z., YANG, F., CAO, W., YANG, J., MA, C., ZHAO, Z., TIAN, H., LIU, X., MA, J., XIAO, S. & ZHENG, H. 2021. Porcine Epidemic Diarrhea Virus Membrane Protein Interacted with IRF7 to Inhibit Type I IFN Production during Viral Infection. J Immunol, 206, 2909-2923.

    21. LI, Z., MA, Z., LI, Y., GAO, S. & XIAO, S. 2020. Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines. Microb Pathog, 149, 104553.

    22. LIN, S., HUA, W., WANG, S., ZHANG, Y., CHEN, X., LIU, H., SHAO, L., CHEN, J. & ZHANG, W. 2022. In vitro assessment of 17 antimicrobial agents against clinical Mycobacterium avium complex isolates. BMC Microbiol, 22, 175.

    23. LIU, Y., YANG, X., GAN, J., CHEN, S., XIAO, Z. X. & CAO, Y. 2022. CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res, 50, W159-w164.

    24. LUO, Y. R., ZHOU, S. T., YANG, L., LIU, Y. P., JIANG, S. Y., DAWULI, Y., HOU, Y. X., ZHOU, T. X. & YANG, Z. B. 2020. Porcine Epidemic Diarrhoea Virus Induces Cell-cycle Arrest through the DNA Damage-signalling Pathway. J Vet Res, 64, 25-32.

    25. MIRNEJAD, R., ASADI, A., KHOSHNOOD, S., MIRZAEI, H., HEIDARY, M., FATTORINI, L., GHODOUSI, A. & DARBAN-SAROKHALIL, D. 2018. Clofazimine: A useful antibiotic for drug-resistant tuberculosis. Biomed Pharmacother, 105, 1353-1359.

    26. PENG, Q., FAN, B., SONG, X., HE, W., WANG, C., ZHAO, Y., GUO, W., ZHANG, X., LIU, S., GAO, J., LI, K., ZHANG, B., ZHOU, J., LI, Y., GUO, R. & LI, B. 2023. Genetic signatures associated with the virulence of porcine epidemic diarrhea virus AH2012/12. J Virol, 97, e0106323.

    27. RASHIDA Z, L. S. 2021. The pentose phosphate pathway and organization of metabolic networks enabling growth programs. Curr Opin Syst Biol, 28, 100390.

    28. SU, M., SHI, D., XING, X., QI, S., YANG, D., ZHANG, J., HAN, Y., ZHU, Q., SUN, H., WANG, X., WU, H., WANG, M., WEI, S., LI, C., GUO, D., FENG, L. & SUN, D. 2021. Coronavirus Porcine Epidemic Diarrhea Virus Nucleocapsid Protein Interacts with p53 To Induce Cell Cycle Arrest in S-Phase and Promotes Viral Replication. J Virol, 95, e0018721.

    29. TANG, T., BIDON, M., JAIMES, J. A., WHITTAKER, G. R. & DANIEL, S. 2020. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antiviral Res, 178, 104792.

    30. TEAM, C. D., BOITREAUD, J., DENT, J., MCPARTLON, M., MEIER, J., REIS, V., ROGOZHONIKOV, A. & WU, K. 2024. Chai-1: Decoding the molecular interactions of life. bioRxiv, 2024.10.10.615955.

    31. WANG, D., GE, X., CHEN, D., LI, J., CAI, Y., DENG, J., ZHOU, L., GUO, X., HAN, J. & YANG, H. 2018. The S Gene Is Necessary but Not Sufficient for the Virulence of Porcine Epidemic Diarrhea Virus Novel Variant Strain BJ2011C. J Virol, 92, e00603-e00618.

    32. WANG, K., XIE, C., ZHANG, J., ZHANG, W., YANG, D., YU, L., JIANG, Y., YANG, S., GAO, F., YANG, Z., ZHOU, Y. & TONG, G. 2016. The Identification and Characterization of Two Novel Epitopes on the Nucleocapsid Protein of the Porcine Epidemic Diarrhea Virus. Sci Rep, 6, 39010.

    33. WANG, L., XIA, Z., TANG, W., SUN, Y., WU, Y., KWOK, H. F., SUN, F. & CAO, Z. 2022. p38 activation and viral infection. Expert Rev Mol Med, 24, e4.

    34. WANG, S., WANG, Z., LI, Y., TU, S., ZOU, J., CHENG, Y., ZHANG, H., SUOLANG, S. & ZHOU, H. 2023a. Generation of whole-porcine neutralizing antibodies of an alphacoronavirus by single B cell antibody technology. Antiviral Res, 220, 105754.

    35. WANG, X., LU, L. & JIANG, S. 2023b. SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread. Signal Transduct Target Ther, 8, 439.

    36. WANG, Y., HUANG, H., LI, D., ZHAO, C., LI, S., QIN, P., LI, Y., YANG, X., DU, W., LI, W. & LI, Y. 2023c. Identification of niclosamide as a novel antiviral agent against porcine epidemic diarrhea virus infection by targeting viral internalization. Virol Sin, 38, 296-308.

    37. WANG, Z., SONI, V., MARRINER, G., KANEKO, T., BOSHOFF, H. I. M., BARRY, C. E., 3RD & RHEE, K. Y. 2019. Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline. Proc Natl Acad Sci U S A, 116, 19646-19651.

    38. WU, J., CAO, S., LEI, S., LIU, Q., LI, Y., YU, Y., XIE, H., LI, Q., ZHAO, X., CHEN, R., HUANG, W., XIAO, X., YU, Y., SONG, D., LI, Y. & WANG, Y. 2021. Clofazimine: A Promising Inhibitor of Rabies Virus. Front Pharmacol, 12, 598241.

    39. WU, Y., LI, M., TIAN, J., YAN, H., PAN, Y., SHI, H., SHI, D., CHEN, J., GUO, L. & FENG, L. 2023. Broad antagonism of coronaviruses nsp5 to evade the host antiviral responses by cleaving POLDIP3. PLoS Pathog, 19, e1011702.

    40. XIE, Y., GUO, X., HU, T., WEI, D., MA, X., WU, J., HUANG, B. & SHEN, J. 2021. Significant Inhibition of Porcine Epidemic Diarrhea Virus In Vitro by Remdesivir, Its Parent Nucleoside and β-D-N(4)-hydroxycytidine. Virol Sin, 36, 997-1005.

    41. XU, Q., WANG, F., JIAO, W., ZHANG, M., XING, G., FENG, H., SUN, X., HU, M. & ZHANG, G. 2023. Virtual Screening-Based Peptides Targeting Spike Protein to Inhibit Porcine Epidemic Diarrhea Virus (PEDV) Infection. Viruses, 15, 381.

    42. YANG, S., HUANG, X., LI, S., WANG, C., JANSEN, C. A., SAVELKOUL, H. F. J. & LIU, G. 2023. Linoleic acid: a natural feed compound against porcine epidemic diarrhea disease. J Virol, 97, e0170023.

    43. YANG, X., LIU, Y., GAN, J., XIAO, Z. X. & CAO, Y. 2022. FitDock: protein-ligand docking by template fitting. Brief Bioinform, 23, bbac087.

    44. YE, G., DENG, F., SHEN, Z., LUO, R., ZHAO, L., XIAO, S., FU, Z. F. & PENG, G. 2016. Structural basis for the dimerization and substrate recognition specificity of porcine epidemic diarrhea virus 3C-like protease. Virology, 494, 225-235.

    45. YUAN, S., YIN, X., MENG, X., CHAN, J. F., YE, Z. W., RIVA, L., PACHE, L., CHAN, C. C., LAI, P. M., CHAN, C. C., POON, V. K., LEE, A. C., MATSUNAGA, N., PU, Y., YUEN, C. K., CAO, J., LIANG, R., TANG, K., SHENG, L., DU, Y., XU, W., LAU, C. Y., SIT, K. Y., AU, W. K., WANG, R., ZHANG, Y. Y., TANG, Y. D., CLAUSEN, T. M., PIHL, J., OH, J., SZE, K. H., ZHANG, A. J., CHU, H., KOK, K. H., WANG, D., CAI, X. H., ESKO, J. D., HUNG, I. F., LI, R. A., CHEN, H., SUN, H., JIN, D. Y., SUN, R., CHANDA, S. K. & YUEN, K. Y. 2021. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2. Nature, 593, 418-423.

    46. ZHAI, X., KONG, N., ZHANG, Y., SONG, Y., QIN, W., YANG, X., YE, C., YE, M., TONG, W., LIU, C., ZHENG, H., YU, H., ZHANG, W., YANG, X., ZHANG, G., TONG, G. & SHAN, T. 2023. N protein of PEDV plays chess game with host proteins by selective autophagy. Autophagy, 19, 2338-2352.

    47. ZHANG, H., ZOU, C., PENG, O., ASHRAF, U., XU, Q., GONG, L., FAN, B., ZHANG, Y., XU, Z., XUE, C., WEI, X., ZHOU, Q., TIAN, X., SHEN, H., LI, B., ZHANG, X. & CAO, Y. 2023. Global Dynamics of Porcine Enteric Coronavirus PEDV Epidemiology, Evolution, and Transmission. Mol Biol Evol, 40, msad052.

    48. ZHANG, S., CAO, Y. & YANG, Q. 2020. Transferrin receptor 1 levels at the cell surface influence the susceptibility of newborn piglets to PEDV infection. PLoS Pathog, 16, e1008682.

    49. ZHANG, S., SHI, W., FENG, J., ZHANG, W. & ZHANG, Y. 2017. Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro. Emerg Microbes Infect, 6, e28.

  • 加载中
  • 10.1016j.virs.2025.05.012-ESM2.xls
    10.1016j.virs.2025.05.012-ESM1.docx

Figures(1)

Article Metrics

Article views(4839) PDF downloads(9) Cited by(0)

Related
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Clofazimine targeting the spike protein and RdRp exhibits highly efficient antiviral activity against porcine epidemic diarrhea virus in vitro

      Corresponding author: Zhibiao Yang, zbyang@sjtu.edu.cn
      Corresponding author: Zhe Wang, wangz@sjtu.edu.cn
    • a. Shanghai Collaborative Innovation Center of Agri-Seeds/School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, 200240, China;
    • b. Shanghai Key Laboratory of Veterinary Biotechnology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, 200240, China;
    • c. Department of Swine Infectious Diseases, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Shanghai, 200241, China;
    • d. College of Agronomy and Biotechnology, China Agricultural University, Beijing, 100094, China

    Abstract: Porcine epidemic diarrhea virus (PEDV) infection causes acute watery diarrhea in neonatal piglets, leading to substantial economic losses within the pig farming industry. This study demonstrates that clofazimine (CFZ) significantly inhibits PEDV replication in a dose-dependent manner in vitro, with negligible cytotoxicity. Findings from our time-of-addition assays indicate that CFZ effectively disrupts multiple stages of the viral infection cycle. Using a CoV-RdRp-Gluc reporter system, we evaluated the potency of CFZ against PEDV RNA-dependent RNA polymerase (RdRp), and determined a low IC50 value of 0.1364 μM. Molecular docking studies further confirmed that CFZ has high binding affinity at the active sites of the spike protein and RdRp protein in PEDV. Transcriptome analysis of Vero E6 cells, with and without CFZ treatment, revealed a significant change in transcriptional activity at 8 h post-infection (hpi). Moreover, the simultaneous application of CFZ and nucleoside analogs showed enhanced the anti-PEDV effect of CFZ in vitro. Our study underscores the potential of CFZ as a viable therapeutic agent against PEDV.

    Figure (1)  Reference (49) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return